AstraZeneca Files Visacor, Axalin As Tradenames For Cardio Therapies
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
AstraZeneca is expanding the list of potential tradenames for its cardiovascular pipeline with the submission of the names Visacor and Axalin to the Patent and Trademark Office for approval.